Post-approval studies (Phase 4)UnknownNCT04636918What this trial is testingIkervis for DED Due to GVHD Post Allo-HSCTWho this might be right forLeukemia (Both ALL and AML)MDS-EB-1 Singapore Eye Research Institute 40
Early research (Phase 1)Ended earlyNCT05933070What this trial is testingA Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AMLWho this might be right forCancerMDS-EBMyelodysplastic Syndromes+2 more Inmune Bio, Inc. 2